143 related articles for article (PubMed ID: 25173477)
1. Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China.
Wang Y; Dong D; Cheng G; Zuo S; Liu D; Du X
Vaccine; 2014 Oct; 32(44):5875-9. PubMed ID: 25173477
[TBL] [Abstract][Full Text] [Related]
2. Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005-2012.
Liu Y; Lin H; Zhu Q; Wu C; Zhao Z; Zheng H
Vaccine; 2014 Mar; 32(15):1768-73. PubMed ID: 24503272
[TBL] [Abstract][Full Text] [Related]
3. Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008-2013.
Wu W; Liu D; Li K; Nuorti JP; Nohynek HM; Xu D; Ye J; Zheng J; Wang H
Vaccine; 2017 Jun; 35(29):3666-3671. PubMed ID: 28552510
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
Hills SL; Soeung SC; Sarath S; Morn C; Dara C; Fischer M; Thigpen MC
PLoS One; 2022; 17(6):e0269480. PubMed ID: 35679297
[TBL] [Abstract][Full Text] [Related]
5. Allergic reactions to Japanese encephalitis vaccine.
Plesner AM
Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
[TBL] [Abstract][Full Text] [Related]
6. A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka.
De Alwis KN; Abeysinghe MR; Wickramesinghe AR; Wijesinghe PR
Vaccine; 2014 Feb; 32(8):924-30. PubMed ID: 24406391
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.
Guo B; Page A; Wang H; Taylor R; McIntyre P
Vaccine; 2013 Jan; 31(4):603-17. PubMed ID: 23200940
[TBL] [Abstract][Full Text] [Related]
8. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012.
Rabe IB; Miller ER; Fischer M; Hills SL
Vaccine; 2015 Jan; 33(5):708-12. PubMed ID: 25498208
[TBL] [Abstract][Full Text] [Related]
9. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.
Ginsburg AS; Meghani A; Halstead SB; Yaich M
Hum Vaccin Immunother; 2017 Oct; 13(10):2222-2231. PubMed ID: 28841362
[TBL] [Abstract][Full Text] [Related]
10. Adverse events following immunization with the live-attenuated recombinant Japanese encephalitis vaccine (IMOJEV®) in Taiwan, 2017-18.
Ma HY; Lai CC; Chiu NC; Lee PI
Vaccine; 2020 Jul; 38(33):5219-5222. PubMed ID: 32546414
[TBL] [Abstract][Full Text] [Related]
11. Safety of concomitant administration of inactivated hepatitis A vaccine with other vaccines in children under 16 years old in post-marketing surveillance.
Wu L; Yang S; Huang Z; Liu J; Guo X; Bai Q; Sun X
Vaccine; 2023 Mar; 41(14):2412-2417. PubMed ID: 36872142
[TBL] [Abstract][Full Text] [Related]
12. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
[TBL] [Abstract][Full Text] [Related]
13. Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports.
Jia N; Zhao QM; Guo XF; Cheng JX; Wu C; Zuo SQ; Dai PF; Zhao JY; Zhang JS
BMC Infect Dis; 2011 Dec; 11():344. PubMed ID: 22168358
[TBL] [Abstract][Full Text] [Related]
14. Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand.
Chotpitayasunondh T; Pruekprasert P; Puthanakit T; Pancharoen C; Tangsathapornpong A; Oberdorfer P; Kosalaraksa P; Prommalikit O; Tangkittithaworn S; Kerdpanich P; Techasaensiri C; Korejwo J; Chuenkitmongkol S; Houillon G
Vaccine; 2017 Jan; 35(2):299-304. PubMed ID: 27903416
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
[TBL] [Abstract][Full Text] [Related]
16. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14-14-2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial.
Li Y; Chu SY; Yue C; Wannemuehler K; Xie S; Zhang F; Wang Y; Zhang Y; Ma R; Li Y; Zuo Z; Rodewald L; Xiao Q; Feng Z; Wang H; An Z
Lancet Infect Dis; 2019 Apr; 19(4):402-409. PubMed ID: 30833160
[TBL] [Abstract][Full Text] [Related]
18. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].
Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620
[TBL] [Abstract][Full Text] [Related]
19. Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China.
Meng FY; Sun Y; Shen YG; Pan HF; Tang JH; Wang BB; Wu CH; Ye DQ
PLoS One; 2017; 12(2):e0172108. PubMed ID: 28192490
[TBL] [Abstract][Full Text] [Related]
20. Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO(®).
Schuller E; Klingler A; Dubischar-Kastner K; Dewasthaly S; Müller Z
Vaccine; 2011 Nov; 29(47):8669-76. PubMed ID: 21907747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
